[Federal Register Volume 72, Number 35 (Thursday, February 22, 2007)]
[Notices]
[Page 8017]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-2992]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in schedule I or II and prior to issuing a 
regulation under 21 U.S.C. Sec.  952(a)(2)(B) authorizing the 
importation of such a substance, provide manufacturers holding 
registrations for the bulk manufacture of the substance an opportunity 
for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on November 27, 2005, Cambrex Charles City, Inc., 1205 11th 
Street, Charles City, Iowa 50616, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as an importer 
of Phenylacetone (8501), a basic class of controlled substance listed 
in schedule II.
    The company plans to import Phenylacetone for use as a precursor in 
the manufacture of amphetamines only.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic class of controlled 
substance may file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43 and in 
such form as prescribed by 21 CFR 1316.47.
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than March 26, 2007.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR Sec.  1301.34(b), 
(c), (d), (e) and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, (40 FR 43745-46), all 
applicants for registration to import a basic class of any controlled 
substance listed in schedule I or II are, and will continue to be 
required to demonstrate to the Deputy Assistant Administrator, Office 
of Diversion Control, Drug Enforcement Administration, that the 
requirements for such registration pursuant to 21 U.S.C. 958(a), 21 
U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e) and (f) are 
satisfied.

    Dated: February 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration. .
 [FR Doc. E7-2992 Filed 2-21-07; 8:45 am]
BILLING CODE 4410-09-P